• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai, Jan. 23

JB Chemicals & Pharmaceuticals Ltd has posted a 2.09 per cent increase in profit after tax at Rs 19.51 crore (Rs 19.11 crore) for the third quarter ended December 31, 2006. Net sales have increased by 3.77 per cent to Rs 135.1 crore (Rs 130.19 crore). Total income (net of excise) has increased from Rs 131.73 crore to Rs 137.45 crore.

During the quarter, the company had signed an agreement to make an investment of $5.1 million in South African-based Biotech Laboratories Ltd. Shares of the company rose 2.11 per cent to close at Rs 104.10 on BSE.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Grasim Q3 net doubles on higher sales realisations

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line